Anwendung von hochdosierten intraven̈sen Immunglobulinen in der Dermatologie

Translated title of the contribution: Use of high-dose immunoglobulins in dermatology

Alexander Enk*, Gerhard Fierlbeck, Lars French, Michael Hertl, Gerald Messer, Michael Meurer, Kerstin Steinbrink, Georg Stingl, Beatrice Volc-Platzer, Detlef Zillikens

*Corresponding author for this work
17 Citations (Scopus)


The recommendations presented here for the therapeutic use of IV Ig in dermatology demonstrate the significance of IVIg therapy for numerous autoimmune diseases of the skin and for toxic epidermal necrolysis. The role of IVIg therapy in otherwise therapy-recalcitrant diseases is undisputed. The therapeutic recommendations for the above-mentioned diseases thus rest on solid data. In view of the to-date unclear mechanism of action of IVIg in vivo, further efforts must be made to develop suitable standard therapies for the affected patient populations. This demands performing and evaluating even more extensive case series in different clinics. The therapeutic recommendations presented here could serve as foundation. The introduction of this EU guideline in clinical practice will optimize the use of IVIg in dermatology all over Europe.

Translated title of the contributionUse of high-dose immunoglobulins in dermatology
Original languageGerman
JournalJDDG - Journal of the German Society of Dermatology
Issue number9
Pages (from-to)806-812
Number of pages7
Publication statusPublished - 09.2009


Dive into the research topics of 'Use of high-dose immunoglobulins in dermatology'. Together they form a unique fingerprint.

Cite this